Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Cordless Handheld Device Uses Vibrations to Eliminate Fingerstick Pain for Blood Sugar Testing

By LabMedica International staff writers
Posted on 10 Nov 2021

A new portable tool uses innovative vibration technology to improve the ease of diabetes management. More...

BING Innovations, LLC (Boca Raton, FL, USA) has launched DigiVibe, a cordless handheld device that uses vibrations to eliminate the pain of getting the finger pricked. Specifically designed for blood glucose monitoring, DigiVibe applies vibration directly to the finger, blocking pain signals to the brain and helping to make the process more tolerable for both children and adults.

While many people only get their finger-pricked at their annual checkup, for those with diabetes, glucose monitoring means having to prick their finger three or more times each day. DigiVibe, an FDA-registered and CE-certified device, has been created to reduce the pain and anxiety of checking glucose levels, whether a person is not keen on needles or just weary of repeated finger pricks. The easy-to-use and portable device adheres to any flat surface for hands-free use, making self-testing and diabetes management easier and more convenient than ever before. For a doctor who regularly deals with diabetic patients or an individual who must test their glucose levels regularly, the DigiVibe device can make the process easier and virtually painless - in as little as 12 seconds.

The DigiVibe Starter Kit includes a sleek carrying case containing one DigiVibe device, stand and tip, lancing device, five 30-gauge lancets, and one AA lithium battery. The battery is designed to last for approximately three months or roughly 450 finger sticks for a single user. Plus, there is enough space in the carrying case to fit one’s regular test strips and glucose testing device. Additional accessories or refills of supplies can also be ordered anytime on the DigiVibe website. One-time use disposable tips and lancing devices are also available for medical practitioners.

"The conventional way to test blood sugar for diabetes is often associated with pain, discomfort, and even fear, but DigiVibe has set out to dramatically make this experience better," said Dr. Marcelo Bendix, Endocrinologist and DigiVibe Medical Advisor. "Pain and finger soreness are among the top reasons diabetics sometimes skip blood glucose testing, which is not only dangerous, but makes it quite difficult for them to effectively manage diabetes. DigiVibe is truly a game-changer; it will allow patients to stay on top of their glucose testing and no longer fear the dreaded finger-prick they have to endure in the doctor's office and at home."

Related Links:
BING Innovations, LLC 


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Glucose Reference Analyzer
Nova Primary
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.